AU2002239882A1 - Method for identifying a ligand for a biological substrate - Google Patents

Method for identifying a ligand for a biological substrate

Info

Publication number
AU2002239882A1
AU2002239882A1 AU2002239882A AU2002239882A AU2002239882A1 AU 2002239882 A1 AU2002239882 A1 AU 2002239882A1 AU 2002239882 A AU2002239882 A AU 2002239882A AU 2002239882 A AU2002239882 A AU 2002239882A AU 2002239882 A1 AU2002239882 A1 AU 2002239882A1
Authority
AU
Australia
Prior art keywords
biological substrate
ligand
identifying
binding
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002239882A
Inventor
Mathai Mammen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innoviva Inc
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Publication of AU2002239882A1 publication Critical patent/AU2002239882A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein

Abstract

A method of identifying a ligand for a second binding site (5) on a biological substrate (1) is disclosed. The method comprises determining the effect of a candidate compound (9) on the binding of a probe compound (2) which binds to a first binding site (3) on the biological substrate in the presence of a first multibinding compound (4) which binds to the first (3) and second (5) binding sites on the biological substrate (1).
AU2002239882A 2001-01-11 2002-01-10 Method for identifying a ligand for a biological substrate Abandoned AU2002239882A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/758,916 2001-01-11
US09/758,916 US6656694B2 (en) 2001-01-11 2001-01-11 Method for identifying a ligand for a biological substrate
PCT/US2002/000807 WO2002056016A2 (en) 2001-01-11 2002-01-10 Method for identifying a ligand for a biological substrate

Publications (1)

Publication Number Publication Date
AU2002239882A1 true AU2002239882A1 (en) 2002-07-24

Family

ID=25053626

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002239882A Abandoned AU2002239882A1 (en) 2001-01-11 2002-01-10 Method for identifying a ligand for a biological substrate

Country Status (7)

Country Link
US (1) US6656694B2 (en)
EP (1) EP1350108B1 (en)
JP (1) JP4111830B2 (en)
AT (1) ATE328276T1 (en)
AU (1) AU2002239882A1 (en)
DE (1) DE60211849T2 (en)
WO (1) WO2002056016A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020172967A1 (en) * 2001-02-13 2002-11-21 Gadek Thomas R. Identification of non-covalent complexes by mass spectrometry
JP2007524641A (en) * 2003-07-11 2007-08-30 セラヴァンス， インコーポレーテッド Substituted 4-amino-1-benzylpiperidine compounds
JP2007528412A (en) * 2004-03-11 2007-10-11 セラヴァンス， インコーポレーテッド Biphenyl compounds useful as muscarinic receptor antagonists
JP2007528415A (en) * 2004-03-11 2007-10-11 セラヴァンス， インコーポレーテッド Useful biphenyl compounds as muscarinic receptor antagonists
WO2005087739A1 (en) * 2004-03-11 2005-09-22 Theravance, Inc. Biphenyl compounds useful as muscarinic receptor antagonists
EP1723115A1 (en) 2004-03-11 2006-11-22 Theravance, Inc. Biphenyl compounds useful as muscarinic receptor antagonists
TW200538095A (en) * 2004-03-11 2005-12-01 Theravance Inc Biphenyl compounds useful as muscarinic receptor antagonists
TWI341836B (en) 2004-03-11 2011-05-11 Theravance Inc Biphenyl compounds useful as muscarinic receptor antagonists
US7456199B2 (en) * 2004-03-11 2008-11-25 Theravance, Inc. Biphenyl compounds useful as muscarinic receptor antagonists
JP2007528408A (en) 2004-03-11 2007-10-11 セラヴァンス， インコーポレーテッド Useful biphenyl compounds as muscarinic receptor antagonists
US20060052943A1 (en) * 2004-07-28 2006-03-09 Karthik Ramani Architectures, queries, data stores, and interfaces for proteins and drug molecules
US7659403B2 (en) * 2005-03-10 2010-02-09 Theravance, Inc. Biphenyl compounds useful as muscarinic receptor antagonists
US7642355B2 (en) * 2005-03-10 2010-01-05 Theravance, Inc. Biphenyl compounds useful as muscarinic receptor antagonists
WO2006099031A1 (en) * 2005-03-10 2006-09-21 Theravance, Inc. Biphenyl compounds useful as muscarinic receptor antagonists
TW200714587A (en) * 2005-03-10 2007-04-16 Theravance Inc Biphenyl compounds useful as muscarinic receptor antagonists
EP1856112A1 (en) * 2005-03-10 2007-11-21 Theravance, Inc. Biphenyl compounds useful as muscarinic receptor antagonists
JP2008546695A (en) 2005-06-13 2008-12-25 セラヴァンス， インコーポレーテッド Biphenyl compounds useful as muscarinic receptor antagonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3882904T2 (en) 1987-09-30 1993-11-18 Beckman Instruments Inc Two-tooth conjugate and process for its use.
DE69331570T2 (en) 1992-10-21 2002-10-02 Dade Behring Inc Agglutination test using a multivalent ligand
US5698401A (en) 1995-11-14 1997-12-16 Abbott Laboratories Use of nuclear magnetic resonance to identify ligands to target biomolecules
EP0901629A4 (en) 1996-03-21 2000-02-02 Univ Princeton Carbohydrate-based ligand library, assay and method
US6011137A (en) 1996-04-03 2000-01-04 University Of North Carolina At Chapel Hill Identification and isolation of novel polypeptides having WW domains and methods of using same
WO1999025384A2 (en) 1997-11-17 1999-05-27 University Of Miami Multimeric tethered ligands and their use in receptor-ligand interactions
EP1060189A1 (en) 1998-02-20 2000-12-20 Advanced Medicine, Inc. Derivatives of glycopeptide antibacterial agents
EP1086065A1 (en) 1998-06-08 2001-03-28 Advanced Medicine, Inc. Combinatorial synthesis of multibinding libraries
US6335155B1 (en) 1998-06-26 2002-01-01 Sunesis Pharmaceuticals, Inc. Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules

Also Published As

Publication number Publication date
WO2002056016A2 (en) 2002-07-18
US20020090645A1 (en) 2002-07-11
EP1350108B1 (en) 2006-05-31
WO2002056016A3 (en) 2003-02-06
DE60211849D1 (en) 2006-07-06
EP1350108A2 (en) 2003-10-08
DE60211849T2 (en) 2006-11-23
JP4111830B2 (en) 2008-07-02
ATE328276T1 (en) 2006-06-15
JP2005501218A (en) 2005-01-13
US6656694B2 (en) 2003-12-02

Similar Documents

Publication Publication Date Title
AU2002239882A1 (en) Method for identifying a ligand for a biological substrate
EP0915173A3 (en) Kit and method for fluorescence based detection assay
AU2002346484A1 (en) Method and apparatus for improving the accuracy of alternative site analyte concentration measurements
DE69838748D1 (en) DETERMINATION OF MOLECULAR INTERACTIONS BY MARKERS SUB-UNITS COMPLEMENTATION
WO2002095356A3 (en) Methods and compositions for analyzing proteins
AU4932099A (en) Methods for fractional quantification of cholesterol in lipoproteins and quantification reagents
AU6162999A (en) Apoptosis marker antibodies and methods of use
AU2001274829A1 (en) Method for detection of biological related materials using biomarkers
AU8218591A (en) Method for reducing interference in a fluorescent assay
WO2003054225A3 (en) Method for determining nucleic acid analytes
CA2341263A1 (en) Enzyme inhibition immunoassay
DE69604920D1 (en) USE OF A PHYCOBILIPROTEIN-PEPTIDE COMPLEX COMPOUND AS A FLUORESCENT LABEL
CA2339821A1 (en) Enzymatic measurement of mycophenolic acid
AU7571998A (en) Rapid evaluation of the ratio of biological molecules
AU2707597A (en) Method of assay
AU2003274065A1 (en) New probe plate based on antigen-antibody reaction and reagent kit and method using the probe plate
AU2001286915A1 (en) Method for simplified shipping of clinical specimens and optional direct analysis
DE60332479D1 (en) HOLO-TRANSCOBALAMIN BINDING PARTNER AND ITS USE IN COBALAMINTEST
AU2002317672A1 (en) Method for the biochemical detection of analytes
EP1441224A3 (en) Enzyme inhibition immunoassay
AU2001267922A1 (en) Method of assaying the function of fc fragment of antibody
DE60012723D1 (en) METHOD FOR DETERMINING DISACCHARIDASES
WO2002086505A3 (en) Intracellular analysis
FR2801677B1 (en) METHOD FOR ANALYZING A SAMPLE FOR THE POSSIBLE PRESENCE OF LEGIONELLA INCLUDING AN IMMUNOCAPTURE STAGE
EP1156331B8 (en) Immunoassay for H. Pylori in fecal specimens using genus specific monoclonal antibody

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase